Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126438541 | 12643854 | 1 | I | 20130520 | 20130521 | 20160811 | 20160811 | EXP | US-UNITED THERAPEUTICS-UTC-033184 | UNITED THERAPEUTICS | 83.92 | YR | M | Y | 0.00000 | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126438541 | 12643854 | 1 | PS | TYVASO | TREPROSTINIL | 1 | 72 ?G, UNK | 22387 | INHALATION GAS | ||||||||||
| 126438541 | 12643854 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Oral | 20 MG, UNK | U | U | 0 | 20 | MG | ||||||
| 126438541 | 12643854 | 3 | SS | TRACLEER | BOSENTAN | 1 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126438541 | 12643854 | 1 | Pulmonary arterial hypertension |
| 126438541 | 12643854 | 2 | Product used for unknown indication |
| 126438541 | 12643854 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126438541 | 12643854 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126438541 | 12643854 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126438541 | 12643854 | 1 | 20110923 | 0 | ||
| 126438541 | 12643854 | 2 | 20121109 | 0 |